IdentificationGeneric Name(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILEDrugBank Accession NumberDB08676BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


Download MOLSDFPDBSMILESInChI


 Similar StructuresStructure for (20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE (DB08676)× CloseWeightAverage: 453.5356 Monoisotopic: 453.216475133 Chemical FormulaC27H27N5O2SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaNot AvailableHumansUProtein farnesyltransferase subunit betaNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableClassificationNot classifiedAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyGBEQWWUQNVMGMR-LLHWJCAFSA-NInChIInChI=1S/C27H27N5O2/c28-14-20-5-4-18-12-26(20)34-22-7-6-19-2-1-3-25(23(19)13-22)32-11-9-24(27(32)33)30-10-8-21-15-29-17-31(21)16-18/h1-4,6-7,13,15,17,20,24,26,30H,5,8-12,16H2/t20-,24+,26?/m1/s1IUPAC Name(5S,18R)-31-oxo-20-oxa-2,6,11,13-tetraazahexacyclo[19.6.2.1^{2,5}.1^{15,19}.0^{9,13}.0^{24,28}]hentriaconta-1(27),9,11,15,21(29),22,24(28),25-octaene-18-carbonitrileSMILES[H][C@]12CCN(C1=O)C1=CC=CC3=C1C=C(OC1([H])CC(CN4C=NC=C4CCN2)=CC[C@]1([H])C#N)C=C3ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound131704313PubChem Substance99445147ChemSpider64873355PDBe LigandU66PDB Entries1ld7Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.116 mg/mLALOGPSlogP2.43ALOGPSlogP1.68ChemaxonlogS-3.6ALOGPSpKa (Strongest Acidic)17.66ChemaxonpKa (Strongest Basic)7.61ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count5ChemaxonHydrogen Donor Count1ChemaxonPolar Surface Area83.18 Å2ChemaxonRotatable Bond Count0ChemaxonRefractivity129.92 m3·mol-1ChemaxonPolarizability48.58 Å3ChemaxonNumber of Rings6ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+1.0Blood Brain Barrier+0.9247Caco-2 permeable+0.5389P-glycoprotein substrateSubstrate0.5842P-glycoprotein inhibitor IInhibitor0.5P-glycoprotein inhibitor IINon-inhibitor0.7926Renal organic cation transporterInhibitor0.5326CYP450 2C9 substrateNon-substrate0.8502CYP450 2D6 substrateNon-substrate0.7377CYP450 3A4 substrateSubstrate0.6391CYP450 1A2 substrateInhibitor0.5888CYP450 2C9 inhibitorInhibitor0.5905CYP450 2D6 inhibitorNon-inhibitor0.7424CYP450 2C19 inhibitorInhibitor0.5249CYP450 3A4 inhibitorNon-inhibitor0.68CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.7791Ames testNon AMES toxic0.5258CarcinogenicityNon-carcinogens0.9084BiodegradationNot ready biodegradable0.9939Rat acute toxicity2.6690 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.6561hERG inhibition (predictor II)Non-inhibitor0.5678  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionRab geranylgeranyltransferase activitySpecific FunctionEssential subunit of both the farnesyltransferase and the geranylgeranyltransferase complex. Contributes to the transfer of a farnesyl or geranylgeranyl moiety from farnesyl or geranylgeranyl dipho...Gene NameFNTAUniprot IDP49354Uniprot NameProtein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaMolecular Weight44408.32 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] 


 Details2. Protein farnesyltransferase subunit betaKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionZinc ion bindingSpecific FunctionEssential subunit of the farnesyltransferase complex. Catalyzes the transfer of a farnesyl moiety from farnesyl diphosphate to a cysteine at the fourth position from the C-terminus of several prote...Gene NameFNTBUniprot IDP49356Uniprot NameProtein farnesyltransferase subunit betaMolecular Weight48773.2 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:33 / Updated at June 12, 2020 16:52 